Justin S. Waters

Maidstone Hospital — United Kingdom

Medicine · Health Sciences

29h-index6.1kcitations89works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(24), Esophageal Cancer Research and Treatment(18), Colorectal Cancer Treatments and Studies(17), Cholangiocarcinoma and Gallbladder Cancer Studies(11), Lymphoma Diagnosis and Treatment(7)

Publications88 total

Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer
International Journal of Gynecological Cancer·2024· 1 cited
Immunotherapy toxicity prediction in patients with melanoma using machine learning algorithms.
Journal of Clinical Oncology·2024
Novel machine learning algorithm to predict response to immunotherapy in patients with small cell and non-small cell lung cancer.
Journal of Clinical Oncology·2023· 2 cited
Scaling of ant colony interaction networks
Frontiers in Ecology and Evolution·2023· 2 citedOpen Access
P-88 Clinical role of tumour markers in advanced biliary cancers (ABC) treated with second-line active-symptom-control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC+mFOLFOX) in the randomised phase III, multi-centre, open-label ABC-06 trial
Annals of Oncology·2022· 1 cited
Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial
British Journal of Sports Medicine·2022· 75 citedOpen Access
124 Could change in neoadjuvant chemotherapy regimen after 3 cycles lead to better outcomes in inoperable ovarian cancer?
Ovarian cancer·2021Open Access
Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia
Cancers·2021· 11 citedOpen Access
Second-line FOLFOX chemotherapy for advanced biliary tract cancer – Authors' reply
The Lancet Oncology·2021· 7 cited
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer
JAMA Oncology·2021· 176 citedOpen Access
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
The Lancet Oncology·2021· 713 citedOpen Access
Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins
Acta Oncologica·2021· 5 citedOpen Access
Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins
Research Portal (King's College London)·2021Open Access
FOLFOX as Second-Line Chemotherapy for Advanced Biliary Tract Cancer
SSRN Electronic Journal·2020Open Access
Optimising Chemotherapy for Frail and Older Patients With Advanced Gastroesophageal Cancer: The GO2 Phase III Trial
SSRN Electronic Journal·2020· 1 citedOpen Access
Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma
JAMA Oncology·2019· 18 citedOpen Access
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
Journal of Clinical Oncology·2019· 184 citedOpen Access
Gastrointestinal cancer
2019
Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial.
Journal of Clinical Oncology·2019· 60 cited
ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.
Journal of Clinical Oncology·2019· 226 cited
page 1 of 5Next →

Frequent Co-authors

David Cunningham(25), Ian Chau(10), Jonathan Wadsley(10), Stephen Falk(10), Paul J. Ross(10), Juan W. Valle(9), Gary Middleton(8), Fareeda Y. Coxon(8), Timothy Iveson(8), Daniel H. Palmer(8), Mark Hill(8), Alicia Okines(7), Andrew Wotherspoon(7), Harpreet Wasan(7), Anthony Maraveyas(7), John Bridgewater(7), Claire Saffery(5), Yolanda Barbáchano(5), Alan Anthoney(5), Srinivasan Madhusudan(5)